Tor Biering-Sørensen1, Masatoshi Minamisawa2, Brian Claggett3, Jiankang Liu3, G Michael Felker4, John J V McMurray5, Fady I Malik6, Siddique Abbasi7, Christopher E Kurtz7, John R Teerlink8, Scott D Solomon3. 1. Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Denmark; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. 2. Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Cardiovascular Medicine, Shinshu University Hospital, Matsumoto, Nagano, Japan. 3. Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. 4. Division of Cardiology, Duke University School of Medicine, Durham, NC. 5. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. 6. Cytokinetics, Inc, San Francisco, CA. 7. Amgen, Inc., Thousand Oaks, CA. 8. Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA.
Authors: Fadel Alqatati; Mohammad Elbahnasawy; Seif Bugazia; Khaled Mohamed Ragab; Ahmed Bostamy Elsnhory; Mostafa Shehata; Sarah Makram Elsayed; Mustafa Ali Fathy; Anas Zakarya Nourelden Journal: Indian Heart J Date: 2022-03-15